Is the RSV Shot Worth the Risk to Your Baby?
Favicon 
www.sgtreport.com

Is the RSV Shot Worth the Risk to Your Baby?

by Dr. Joseph Mercola, Mercola: Story at-a-glance Nirsevimab, a new RSV shot for infants, has raised safety concerns after reports of infant deaths following administration. The reporting system for adverse events is unclear, potentially leading to underreporting Unlike conventional vaccines, nirsevimab is a monoclonal antibody. Its widespread use in children is unprecedented, and long-term safety […]